Literature DB >> 11297510

Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Y Zhu1, M I Romero, P Ghosh, Z Ye, P Charnay, E J Rushing, J D Marth, L F Parada.   

Abstract

Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder that affects growth properties of neural-crest-derived cell populations. In addition, approximately one-half of NF1 patients exhibit learning disabilities. To characterize NF1 function both in vitro and in vivo, we circumvent the embryonic lethality of NF1 null mouse embryos by generating a conditional mutation in the NF1 gene using Cre/loxP technology. Introduction of a Synapsin I promoter driven Cre transgenic mouse strain into the conditional NF1 background has ablated NF1 function in most differentiated neuronal populations. These mice have abnormal development of the cerebral cortex, which suggests that NF1 has an indispensable role in this aspect of CNS development. Furthermore, although they are tumor free, these mice display extensive astrogliosis in the absence of conspicuous neurodegeneration or microgliosis. These results indicate that NF1-deficient neurons are capable of inducing reactive astrogliosis via a non-cell autonomous mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297510      PMCID: PMC312666          DOI: 10.1101/gad.862101

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  74 in total

1.  Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development.

Authors:  D P Huynh; T Nechiporuk; S M Pulst
Journal:  Dev Biol       Date:  1994-02       Impact factor: 3.582

2.  Temporal onset of synapsin I gene expression coincides with neuronal differentiation during the development of the nervous system.

Authors:  R H Melloni; L J DeGennaro
Journal:  J Comp Neurol       Date:  1994-04-15       Impact factor: 3.215

3.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.

Authors:  T Jacks; T S Shih; E M Schmitt; R T Bronson; A Bernards; R A Weinberg
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

4.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Authors:  C I Brannan; A S Perkins; K S Vogel; N Ratner; M L Nordlund; S W Reid; A M Buchberg; N A Jenkins; L F Parada; N G Copeland
Journal:  Genes Dev       Date:  1994-05-01       Impact factor: 11.361

5.  Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.

Authors:  H Gu; J D Marth; P C Orban; H Mossmann; K Rajewsky
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

6.  Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.

Authors:  M R Johnson; J E DeClue; S Felzmann; W C Vass; G Xu; R White; D R Lowy
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

7.  Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

Authors:  J Schlegel; A Merdes; G Stumm; F K Albert; M Forsting; N Hynes; M Kiessling
Journal:  Int J Cancer       Date:  1994-01-02       Impact factor: 7.396

8.  Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains.

Authors:  M L Nordlund; T A Rizvi; C I Brannan; N Ratner
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

Review 9.  Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene.

Authors:  M Upadhyaya; D J Shaw; P S Harper
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

View more
  266 in total

Review 1.  Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.

Authors:  Anica Wandler; Kevin Shannon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

2.  Nf1 has an essential role in endothelial cells.

Authors:  Aaron D Gitler; Yuan Zhu; Fraz A Ismat; Min Min Lu; Yasutaka Yamauchi; Luis F Parada; Jonathan A Epstein
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

3.  Transgenic rescue of insulin receptor-deficient mice.

Authors:  Haruka Okamoto; Jun Nakae; Tadahiro Kitamura; Byung-Chul Park; Ioannis Dragatsis; Domenico Accili
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 4.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

5.  Neuronal Ablation of IKK2 Decreases Lesion Size and Improves Functional Outcome after Spinal Cord Injury in Mice.

Authors:  Ditte Gry Ellman; Hans Gram Novrup; Louise Helskov Jørgensen; Minna Christiansen Lund; Minna Yli-Karjanmaa; Pernille Marie Madsen; Jonas Heinrich Vienhues; Safinaz Dursun; John R Bethea; Karin Lykke-Hartmann; Roberta Brambilla; Kate Lykke Lambertsen
Journal:  JSM Neurosurg Spine       Date:  2017-08-10

Review 6.  Semaphorin 3A: A new player in bone remodeling.

Authors:  Ren Xu
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

7.  Differential requirements for semaphorin 3F and Slit-1 in axonal targeting, fasciculation, and segregation of olfactory sensory neuron projections.

Authors:  Jean-François Cloutier; Amar Sahay; Ernie C Chang; Marc Tessier-Lavigne; Catherine Dulac; Alex L Kolodkin; David D Ginty
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 8.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

9.  Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo.

Authors:  Yu Shi; Vijay K Yadav; Nina Suda; X Sherry Liu; X Edward Guo; Martin G Myers; Gerard Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

10.  ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.

Authors:  Yuan Wang; Edward Kim; Xiaojing Wang; Bennett G Novitch; Kazuaki Yoshikawa; Long-Sheng Chang; Yuan Zhu
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.